Inhibitors of spinster homolog 2 (SPNS2) for use in therapy

Abstract

The present disclosure provides SPNS2 inhibitor compounds according to Formula I and their pharmaceutically acceptable salts, and/or tautomers as described in the disclosure, and the disclosure provides their pharmaceutical compositions and methods of use in therapy.

Dependencies are inferred from the claim text.